Literature DB >> 7553971

Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.

H Tamamura1, T Murakami, S Horiuchi, K Sugihara, A Otaka, W Takada, T Ibuka, M Waki, N Yamamoto, N Fujii.   

Abstract

All disulfide analogs (types I, II and III) of protegrin (PG)-1, an 18-residue antimicrobial peptide having two intramolecular disulfide bonds, were synthesized using regioselective disulfide bond formation. Random air-oxidation of the fully reduced PG-1 formed the type III PG-1. In addition, a type III analog containing an amidated carboxy-terminal residue was also prepared. Each analog showed significant and different antibacterial and anti-human immunodeficiency virus (HIV) activity. Deletion of two disulfide bridges caused a significant decrease in activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553971     DOI: 10.1248/cpb.43.853

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  24 in total

1.  Crystallization of antimicrobial pores in membranes: magainin and protegrin.

Authors:  L Yang; T M Weiss; R I Lehrer; H W Huang
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

2.  Interaction of antimicrobial peptide protegrin with biomembranes.

Authors:  David Gidalevitz; Yuji Ishitsuka; Adrian S Muresan; Oleg Konovalov; Alan J Waring; Robert I Lehrer; Ka Yee C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-08       Impact factor: 11.205

3.  Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.

Authors:  D A Steinberg; M A Hurst; C A Fujii; A H Kung; J F Ho; F C Cheng; D J Loury; J C Fiddes
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Haemophilus ducreyi is susceptible to protegrin.

Authors:  K Fortney; P A Totten; R I Lehrer; S M Spinola
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

5.  Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis.

Authors:  B Yasin; R I Lehrer; S S Harwig; E A Wagar
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 6.  Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

Authors:  Colleen R Eade; Matthew P Wood; Alexander M Cole
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

7.  The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage.

Authors:  Jun-qiang Lv; Wen Zhang; Song Wang; Lin Zhao; Rui Ma; Jin-wei Hu; Li-juan Wang; Jie Meng; Chun-lei Zhou; Gang Lin; Rong Lu; Zhi Yao
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

8.  Activity of protegrins against yeast-phase Candida albicans.

Authors:  Y Cho; J S Turner; N N Dinh; R I Lehrer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

9.  Susceptibility of Chlamydia trachomatis to protegrins and defensins.

Authors:  B Yasin; S S Harwig; R I Lehrer; E A Wagar
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken.

Authors:  David J Lynn; Rowan Higgs; Susan Gaines; Joanna Tierney; Tharappel James; Andrew T Lloyd; Mario A Fares; Grace Mulcahy; Cliona O'Farrelly
Journal:  Immunogenetics       Date:  2004-05-18       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.